Your clinical optimization focuses exclusively on finding your therapeutic dose without budget anxiety
SURPASS-2 directly compared tirzepatide (5 mg, 10 mg, and 15 mg weekly) against semaglutide 1 mg weekly, demonstrating HbA1c reductions of 2.01% (22 mmol/mol), 2.24% (24 mmol/mol), and 2.30% (25 mmol/mol) respectively, versus 1.86% (20 mmol/mol) with semaglutide
any reported association is likely indirect, relating to changes in body composition, posture, or activity levels during weight loss rather than a direct pharmacological effect
doi: 10.1074/jbc.M209423200 42 CampbellJEDruckerDJ
With this trio on your side, you'll feel ready to take on whatever comes your way and help support your overall health and wellbeing